ASCO 2020: Combined cediranib and olaparib presents similar activity to standard of care treatment
Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of…
Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of…
An experimental targeted drug could treat a rare type of cancer usually affecting the limbs,…
A team of Massachusetts General Hospital (MGH) investigators has discovered a new combination of drugs…